Extracellular matrix synthesis pathways in human skin fibroblasts (ECM synthesis pathways)

Extracellular matrix (ECM) synthesis pathways in human skin fibroblasts represent the integrated network of biochemical reactions responsible for the production and assembly of structural components such as collagen, elastin, and proteoglycans. These pathways are fundamental to maintaining the structural integrity and mechanical properties of the dermis, primarily regulated by the Transforming Growth Factor-beta (TGF-beta) signaling cascade (Source: PubMed, PMID: 22507511). In healthy skin, a balance exists between ECM synthesis and degradation; however, this balance is disrupted in conditions like photoaging, where collagen production declines, and in fibrotic diseases like scleroderma or keloids, where excessive ECM accumulation occurs (Source: NIH, StatPearls). Therapeutic strategies often focus on modulating these pathways using retinoids to enhance collagen gene expression or inhibitors to reduce the activity of matrix metalloproteinases (MMPs) (Source: PubMed, PMID: 17515510). Because these pathways involve multiple enzymes and receptors rather than a single molecular entity, they are considered a complex biological process rather than a discrete therapeutic target.

Other names

Dermal ECM productionFibroblast collagen synthesisSkin matrix remodelingConnective tissue synthesis pathways

Stimulation of procollagen gene expression via TGF-beta/Smad signaling and inhibition of matrix metalloproteinase (MMP) activity.